Revvity Yönetim
Yönetim kriter kontrolleri 4/4
Revvity CEO'su Prahlad Singh, Jan2019 tarihinde atandı, in görev süresi 7.67 yıldır. in toplam yıllık tazminatı $ 13.81M olup, şirket hissesi ve opsiyonları dahil olmak üzere 8.2% maaş ve 91.8% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.11% ine doğrudan sahiptir ve bu hisseler $ 15.14M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 6.2 yıl ve 8 yıldır.
Anahtar bilgiler
Prahlad Singh
İcra Kurulu Başkanı
US$13.8m
Toplam tazminat
| CEO maaş yüzdesi | 8.18% |
| CEO görev süresi | 7.7yrs |
| CEO sahipliği | 0.1% |
| Yönetim ortalama görev süresi | 6.2yrs |
| Yönetim Kurulu ortalama görev süresi | 8yrs |
Son yönetim güncellemeleri
Recent updates
Anlatı Güncellemesi • Sep 04
RVTY: AI Screening Demand And Sector Recovery Will Support Future Upside
Analysts have raised their implied fair value for Revvity from about $143 to about $158, reflecting updated views on revenue growth, margins, and P/E assumptions in light of higher Street price targets and commentary on improving demand and AI-driven screening opportunities. Analyst Commentary Recent Street research on Revvity points to a more constructive setup in the stock, with several bullish analysts lifting price targets and highlighting improving demand trends in key end markets.
Anlatı Güncellemesi • Aug 20
RVTY: Elevated Multiple And Sector Headwinds Will Challenge 2026 Outlook
Analysts have lifted the fair value estimate for Revvity stock from $90 to $100, pointing to updated price targets in the $115 to $130 range and research that highlights steady sector trends, healthier capital spending, and a higher assumed future P/E multiple, despite more conservative profit margin assumptions. Analyst Commentary on Revvity Recent Street research on Revvity points to a mix of optimism and caution.
Anlatı Güncellemesi • Aug 05
RVTY: AI R&D Tools And Sector Backdrop Will Shape Future Earnings Power
Revvity's analyst price targets have shifted higher, with the updated fair value estimate moving from about $117.13 to roughly $121.07 as analysts factor in relatively stronger revenue growth, improved profit margin assumptions, a slightly lower discount rate, and a more moderate future P/E multiple. Analyst Commentary Recent Street research on Revvity gives you a mix of optimism and caution, with several firms fine tuning targets and ratings ahead of upcoming earnings and sector updates.Anlatı Güncellemesi • Jul 22
RVTY: AI R&D Tools And Sector Tailwinds Will Support Measured Future Earnings Power
Analysts have raised the aggregated price target for Revvity by about $3.49 per share to $117.13, citing updated views on the broader tools and diagnostics sector and the company’s position within that market. Analyst Commentary Recent research on Revvity presents a mix of optimism and caution, with several firms updating targets and ratings based on sector views, valuation and expectations around execution.Seeking Alpha • Jul 13
Revvity: Overvalued On Sentiment
Summary Revvity, Inc. trades near 52-week highs, buoyed by sector M&A momentum but faces fundamental headwinds. RVTY's projected 2026 revenues are flat over 2025, underperforming the Life Sciences sector's 11% annual growth outlook. Despite management optimism on margin expansion and share buybacks, RVTY trades at a 22% EV/EBIT premium to the sector median. I see RVTY as a near-term short opportunity, with no merger premium expected and limited sales growth post-divestiture. Read the full article on Seeking AlphaAnlatı Güncellemesi • Jul 07
RVTY: Sector Recovery And AI R&D Platforms Will Drive Future Upside
The analyst price target for Revvity has been revised slightly higher. The fair value estimate has moved from $140.00 to about $142.88 as analysts factor in generally healthy sector demand, ongoing portfolio cleanup, and a higher assumed future P/E multiple, even as revenue growth and profit margin assumptions are reset to more moderate levels.Analiz Makalesi • Jun 17
Revvity (RVTY) Stock Could Be 10.9% Undervalued Despite Profit And Growth Pressure
Revvity (RVTY) is back in focus after recent commentary highlighted weak organic revenue growth, declining adjusted operating profits, and ongoing annual earnings per share pressure. These factors are sharpening questions about the stock’s core business performance. See our latest analysis for Revvity. At a share price of $101.22, Revvity’s recent 30-day share price return of 7.72% and 90-day gain of 19.18% suggest momentum has picked up, even though the 5-year total shareholder return is...Anlatı Güncellemesi • Jun 15
RVTY: Elevated Multiple And China Exit Will Test 2026 Execution
Revvity's analyst fair value estimate has shifted from $95.00 to $90.00 as analysts factor in more measured assumptions for revenue growth, profit margins, and a higher future P/E, while also weighing recent price target moves and mixed ratings across the Street. Analyst Commentary Recent Street research on Revvity shows a mix of views, with several firms adjusting ratings and price targets in different directions.Anlatı Güncellemesi • Jun 01
RVTY: Q1 Execution And Tools Demand Will Support Measured Future Earnings Power
Revvity's updated analyst price target has shifted to $113.64 from $119.56. This reflects a mix of recent target cuts and raises as analysts factor in revised growth and profitability assumptions, as well as a higher future P/E outlook.Analiz Makalesi • May 08
Revvity, Inc. (NYSE:RVTY) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
Shareholders of Revvity, Inc. ( NYSE:RVTY ) will be pleased this week, given that the stock price is up 14% to US$98.85...Anlatı Güncellemesi • May 05
RVTY: Cautious 2026 Tools Recovery Setup Will Face Execution Debate
Revvity's updated analyst price target edges lower by $4 to reflect revised expectations following several price target cuts and a downgrade, partly offset by a recent upgrade from one research firm. Analyst Commentary Recent Street research on Revvity reflects a cautious tone, with several bearish analysts trimming price targets and reassessing expectations.Anlatı Güncellemesi • Apr 21
RVTY: 2026 Tools Recovery Setup Will Face Mixed Execution Debate
The analyst fair value estimate for Revvity has been reset from $105 to $95, as analysts weigh recent target cuts alongside mixed rating changes and revised assumptions for growth, margins, and future P/E multiples. Analyst Commentary Recent Street research on Revvity has sent mixed signals, with several price target adjustments and at least one downgrade alongside an upgrade.Anlatı Güncellemesi • Apr 06
RVTY: Recent Upgrade Cycle And Q4 Execution Will Drive Future Upside
Revvity's updated analyst price target edges up from $137.63 to $140.00 as analysts factor in a mix of recent target increases from several firms and a more cautious stance from at least one large bank. Analyst Commentary The latest Street research on Revvity reflects a split view, with several bullish analysts lifting price targets and one large bank taking a more cautious approach.Anlatı Güncellemesi • Mar 23
RVTY: 2026 Tools Recovery Setup Will Support Healthier End Markets
Revvity’s analyst price targets have shifted higher by a few dollars across several firms, with analysts pointing to healthier end markets, improving procedure and CapEx trends into 2026, early recovery signs in China, and expectations for the company’s tools exposure as key supports for the updated valuations. Analyst Commentary Recent Street research on Revvity has centered on how much recovery in tools demand and procedure volumes is already reflected in current valuations.Anlatı Güncellemesi • Mar 08
RVTY: 2026 Tools Demand And China Recovery Will Support Higher Earnings Power
Revvity's analyst price target edges higher from $114.63 to $119.56 as analysts factor in updated assumptions around discount rates, modestly slower revenue growth and slightly lower profit margins, along with a higher future P/E multiple supported by a series of recent target raises from Baird, TD Cowen, Evercore ISI, Barclays and Jefferies. Analyst Commentary Bullish analysts have been lifting their price targets in a fairly tight range, which points to a shared view that Revvity's risk or return profile has shifted enough to justify higher valuation assumptions, even as they factor in tempered expectations for revenue growth and margins.Anlatı Güncellemesi • Feb 22
RVTY: Fair Value View Weighs 2026 Recovery Against Policy And China Risks
Analysts have nudged their targets on Revvity higher, with recent $3 to $6 price target increases clustered around a fresh $112 mark. They cite recovering end markets, healthier procedure and CapEx trends into 2026, and early signs of improvement in China as key supports for the updated view.Anlatı Güncellemesi • Feb 08
RVTY: Fair Value View Balances Margin Upside With Policy And China Risks
Analysts have lifted their implied fair value for Revvity by $5 to $105, citing updated assumptions around profit margins, a lower future P/E multiple, and recent price target increases from several firms as key drivers of the recalibration. Analyst Commentary Recent Street research on Revvity has centered on fine tuning price targets and reassessing how much investors are willing to pay for the company, with several firms adjusting their models around margin expectations and appropriate P/E levels.Anlatı Güncellemesi • Jan 25
RVTY: Q4 Margin Ramp And Sector Recovery Thesis Will Drive Upside
Narrative Update Analysts have lifted their price target on Revvity by about US$4 to reflect modestly higher fair value estimates and slightly stronger assumptions for revenue growth, Q4 execution and sector recovery potential into 2026. Analyst Commentary Bullish analysts are leaning constructive on Revvity, pointing to recent quarterly execution, updated guidance and sector trends as support for higher valuation ranges.Anlatı Güncellemesi • Jan 11
RVTY: Q4 Margin Ramp And Buybacks Poised To Meet Cautious Recovery
The analyst price target for Revvity has been nudged higher by about $0.25, reflecting Street analysts' generally constructive view on recovering end markets, Q4 guidance that many see as achievable, and improving sector sentiment, even as some firm specific and China related risks remain in focus. Analyst Commentary Street research on Revvity is mixed but tilts constructive, with several firms nudging price targets higher while one new initiation takes a more cautious stance.Anlatı Güncellemesi • Dec 27
RVTY: Q4 Margin Ramp And Buybacks Will Drive Next Phase
Analysts have nudged their average price target on Revvity modestly higher, reflecting confidence that Q4’s steeper ramp in sales and operating margins is achievable and supported by in-line Q3 organic growth, an earnings beat, and slightly improved forward earnings guidance, despite lingering company specific and macro headwinds. Analyst Commentary Bullish analysts highlight that Q3, while not spectacular, provides a solid springboard for a steeper ramp in Q4 sales and operating margins, which they view as achievable based on in line organic growth and an earnings beat.Analiz Makalesi • Dec 18
Does Revvity (NYSE:RVTY) Have A Healthy Balance Sheet?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Anlatı Güncellemesi • Dec 13
RVTY Q4 Margin Ramp And Buybacks Will Drive Stronger Future Upside
Analysts have modestly raised their blended price target on Revvity to approximately $105 per share, up from around $100. This change reflects increased confidence that the company can deliver a steeper but achievable ramp in Q4 sales and margins while continuing to improve profitability, despite a slightly higher discount rate and lingering near term growth risks.Anlatı Güncellemesi • Nov 29
RVTY: Buyback Program and Guidance Outlook Will Shape Next Phase
Analysts have increased their price target for Revvity to $105 from previous levels. They cite achievable Q4 guidance and an improved profit outlook, despite mixed quarterly results.Anlatı Güncellemesi • Nov 15
RVTY: Recent Buyback Activity and Expanded Partnership Will Drive Near-Term Momentum
Revvity's analyst price target has increased from $99 to $105 per share, as analysts cite improving guidance for the upcoming quarter and stronger than expected recent performance, while noting that some risks remain. Analyst Commentary Analyst sentiment towards Revvity has shifted positively in recent weeks, reflecting improved financial guidance and resilient performance.Anlatı Güncellemesi • Oct 31
RVTY: Operating Margins And Buyback Plan Will Drive Share Recovery Ahead
Analysts have slightly raised their fair value estimate for Revvity by $1 to $113.67. They cite more achievable Q4 guidance and improved margin prospects following the company's recent earnings updates.Anlatı Güncellemesi • Oct 17
Digital Transformation And Advanced Diagnostics Will Create Enduring Value
The consensus analyst price target for Revvity has decreased from $115.19 to $112.67. This change reflects lowered profit margin forecasts, slower revenue growth expectations, and continued market headwinds highlighted in recent research reports.Anlatı Güncellemesi • Oct 03
Digital Transformation And Advanced Diagnostics Will Create Enduring Value
Analysts have slightly reduced their price target for Revvity by $1.63 to $115.19. They cite cautious optimism, as stable core markets are offset by ongoing sector uncertainties and revised forecasts for a slower recovery.Seeking Alpha • Feb 24
Revvity: Acquisitions In High-Growth Sectors, Excellent Debt Levels Create Notable Growth Potential
Summary Revvity has acquired companies in sectors with high-growth potential, such as cell and gene therapies, and precision medicine, among other sectors. The company has strengthened its debt position, reaching a 38.13% liabilities-to-assets ratio, the lowest value in eight years. In addition, it has improved its current ratio. Despite the fact that Revvity will face a weak demand in 2025, the two segments of Revvity expect a high growth rate in the long-term. Read the full article on Seeking AlphaCEO Tazminat Analizi
| Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
|---|---|---|---|
| Jul 05 2026 | n/a | n/a | US$237m |
| Apr 05 2026 | n/a | n/a | US$239m |
| Dec 28 2025 | US$14m | US$1m | US$240m |
| Sep 28 2025 | n/a | n/a | US$232m |
| Jun 29 2025 | n/a | n/a | US$279m |
| Mar 30 2025 | n/a | n/a | US$296m |
| Dec 29 2024 | US$12m | US$1m | US$283m |
| Sep 29 2024 | n/a | n/a | US$258m |
| Jun 30 2024 | n/a | n/a | US$197m |
| Mar 31 2024 | n/a | n/a | US$183m |
| Dec 31 2023 | US$9m | US$1m | US$180m |
| Oct 01 2023 | n/a | n/a | US$213m |
| Jul 02 2023 | n/a | n/a | US$250m |
| Apr 02 2023 | n/a | n/a | US$353m |
| Jan 01 2023 | US$11m | US$1m | US$513m |
| Oct 02 2022 | n/a | n/a | US$599m |
| Jul 03 2022 | n/a | n/a | US$637m |
| Apr 03 2022 | n/a | n/a | US$694m |
| Jan 02 2022 | US$10m | US$1m | US$889m |
| Oct 03 2021 | n/a | n/a | US$1b |
| Jul 04 2021 | n/a | n/a | US$1b |
| Apr 04 2021 | n/a | n/a | US$1b |
| Jan 03 2021 | US$9m | US$900k | US$631m |
| Oct 04 2020 | n/a | n/a | US$412m |
| Jul 05 2020 | n/a | n/a | US$294m |
| Apr 05 2020 | n/a | n/a | US$226m |
| Dec 29 2019 | US$4m | US$645k | US$228m |
Tazminat ve Piyasa: Prahlad 'ın toplam tazminatı ($USD 13.81M ) US pazarındaki benzer büyüklükteki şirketler için ortalamadır ($USD 14.74M ).
Tazminat ve Kazançlar: Prahlad 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.
CEO
Prahlad Singh (61 yo)
7.7yrs
Görev süresi
US$13,809,549
Tazminat
Dr. Prahlad R. Singh, Ph.D. has been the Chief Executive Officer of Revvity, Inc. (formerly known as PerkinElmer, Inc.) since December 30, 2019. Dr. Singh served as the Chairman of the Supervisory Board at...
Liderlik Ekibi
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| CEO, President & Director | 7.7yrs | US$13.81m | 0.11% $ 15.1m | |
| Senior VP & CFO | 4.1yrs | US$5.37m | 0.015% $ 2.1m | |
| Senior Vice President of Global Operations | 8.7yrs | US$2.64m | 0.017% $ 2.3m | |
| Senior VP of Administration | 18.2yrs | US$3.67m | 0.094% $ 13.4m | |
| Senior Vice President & Chief Business Officer | 5.7yrs | US$4.10m | 0.0077% $ 1.1m | |
| Chief Accounting Officer | 3.3yrs | Veri yok | 0.0065% $ 914.6k | |
| Senior VP of Technology & Licensing | 2.7yrs | Veri yok | Veri yok | |
| Senior VP & Chief Scientific Officer | no data | Veri yok | Veri yok | |
| Senior VP of Investor Relations & Head of ESG | no data | Veri yok | Veri yok | |
| Senior VP and Chief People & Culture Officer | no data | Veri yok | Veri yok | |
| Advisor | 6.8yrs | US$16.48m | Veri yok | |
| President of Revvity Signals Software | no data | Veri yok | Veri yok |
6.2yrs
Ortalama Görev Süresi
57yo
Ortalama Yaş
Deneyimli Yönetim: RVTY 'un yönetim ekibi deneyimli ve deneyimlidir ( 6.2 yıldır).
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| CEO, President & Director | 7.1yrs | US$13.81m | 0.11% $ 15.1m | |
| Independent Non-Executive Chairman | 25.7yrs | US$449.98k | 0.064% $ 9.1m | |
| Independent Director | 14.6yrs | US$335.05k | 0.024% $ 3.5m | |
| Independent Director | 10.2yrs | US$320.05k | 0.020% $ 2.8m | |
| Independent Director | 9.9yrs | US$340.05k | 0.019% $ 2.8m | |
| Independent Director | 2.6yrs | US$325.05k | 0.0057% $ 806.9k | |
| Independent Director | 8.9yrs | US$315.05k | 0.013% $ 1.9m | |
| Independent Director | 6.5yrs | US$330.05k | 0.012% $ 1.6m | |
| Independent Director | 2.6yrs | US$315.05k | 0.0057% $ 806.9k | |
| Independent Director | 4.2yrs | US$315.05k | 0.0049% $ 699.1k |
8.0yrs
Ortalama Görev Süresi
64yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: RVTY 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 8 yıldır).
Şirket Analizi ve Finansal Veri Durumu
| Veri | Son Güncelleme (UTC saati) |
|---|---|
| Şirket Analizi | 2026/09/09 11:18 |
| Gün Sonu Hisse Fiyatı | 2026/09/09 00:00 |
| Kazançlar | 2026/07/05 |
| Yıllık Kazançlar | 2025/12/28 |
Veri Kaynakları
Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.
| Paket | Veri | Zaman Çerçevesi | Örnek ABD Kaynağı * |
|---|---|---|---|
| Şirket Finansalları | 10 yıl |
| |
| Analist Konsensüs Tahminleri | +3 yıl |
|
|
| Piyasa Fiyatları | 30 yıl |
| |
| Sahiplik | 10 yıl |
| |
| Yönetim | 10 yıl |
| |
| Önemli Gelişmeler | 10 yıl |
|
* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.
Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.
Analiz Modeli ve Kar Tanesi
Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntılarına Github sayfamızdan ulaşabilirsiniz; ayrıca raporlarımızı nasıl kullanacağınıza dair kılavuzlarımız ve YouTube’da eğitim videolarımız da bulunmaktadır.
Simply Wall St analiz modelini tasarlayan ve oluşturan hakkında bilgi edinin.
Endüstri ve Sektör Metrikleri
Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.
Analist Kaynakları
Revvity, Inc. 40 Bu analistlerden 16, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.
| Analist | Kurum |
|---|---|
| Catherine Ramsey Schulte | Baird |
| Robert Bamberger | Baird |
| Luke Sergott | Barclays |